Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: Applied Biosystems, HTS Biosystems To Develop Functional Proteomics System

NEW YORK, April 29-Applied Biosystems and HTS Biosystems will work together to develop and commercialize a new functional proteomics system, the two companies said today.

 

In this collaboration, the two companies will work to improve HTS Biosystems' FLEX CHIP, which uses surface plasmon resonance technology to reveal protein binding kinetics. The system is being developed to permit high throughput, label-free protein identification. A few early versions have been placed with HTS collaborators.

 

ABI, which owns 18 percent of HTS, did not disclose financial details of the arrangement.

 

The collaboration will "capitalize on Applied Biosystems' expertise in instrument systems development, manufacturing and marketing, and HTS Biosystems' proprietary technology and system integration," said ABI vice president Lauren Linton in a statement.

 

HTS has established similar collaborations with Mitsubishi Chemical, Protein Sciences Corporation, and others. The company is based in Hopkinton, Mass.

 

To see the company press release, click here.

 

 

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.